These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31776698)

  • 61. Identification of locally advanced rectal cancer with low risk of local recurrence.
    Wang QX; Li SH; Zhang X; Xie L; Cai PQ; An X; Pan ZZ; Ding PR
    PLoS One; 2015; 10(1):e0117141. PubMed ID: 25629521
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Robotic versus laparoscopic surgery for mid-low rectal cancer after neoadjuvant chemoradiation therapy: comparison of oncologic outcomes.
    Saklani AP; Lim DR; Hur H; Min BS; Baik SH; Lee KY; Kim NK
    Int J Colorectal Dis; 2013 Dec; 28(12):1689-98. PubMed ID: 23948968
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery for patients with locally advanced rectal cancer: a systematic review and meta-analysis.
    Feng S; Yan P; Zhang Q; Li Z; Li C; Geng Y; Wang L; Zhao X; Yang Z; Cai H; Wang X
    Int J Colorectal Dis; 2020 Aug; 35(8):1355-1369. PubMed ID: 32488419
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Safety and Long-Term Effect Assessment of Neoadjuvant Chemoradiotherapy for Elderly Patients With Locally Advanced Rectal Cancer: A CHN Single-Center Retrospective Study.
    Liu H; Li C; Zhao Z; Guan X; Yang M; Liu Z; Tang Y; Jiang Z; Wang X
    Technol Cancer Res Treat; 2020; 19():1533033820970339. PubMed ID: 33161830
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Textbook outcome in low rectal cancer after neoadjuvant chemoradiotherapy: Post hoc analysis of the LASRE randomized clinical trial.
    Sun Y; Jiang W; Tang Z; Wang X; Huang Y; Chi P
    Eur J Surg Oncol; 2024 Sep; 50(9):108519. PubMed ID: 38950491
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.
    Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY
    PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Indistinguishable T2/T3-N0 rectal cancer on rectal magnetic resonance imaging: comparison of surgery-first and neoadjuvant chemoradiation therapy-first strategies.
    Kim JG; Song KD; Cha DI; Kim HC; Yu JI
    Int J Colorectal Dis; 2018 Oct; 33(10):1359-1366. PubMed ID: 30003363
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

  • 70. Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection After Neoadjuvant Chemoradiation for Initial cT3 Juxta-Anal Rectal Cancer.
    Huang S; Huang Y; Chi P; Lin H; Lu X; Xu Z; Sun Y; Wang X
    J Laparoendosc Adv Surg Tech A; 2019 Jun; 29(6):809-816. PubMed ID: 30596539
    [No Abstract]   [Full Text] [Related]  

  • 71. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy.
    Runau F; Collins A; Fenech GA; Ford E; Dimitriou N; Chaudhri S; Yeung JM
    Int J Colorectal Dis; 2017 Mar; 32(3):341-348. PubMed ID: 27885480
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is a diverting ostomy needed in mid-high rectal cancer patients undergoing a low anterior resection after neoadjuvant chemoradiation? An NSQIP analysis.
    Messaris E; Connelly TM; Kulaylat AN; Miller J; Gusani NJ; Ortenzi G; Wong J; Bhayani N
    Surgery; 2015 Sep; 158(3):686-91. PubMed ID: 26008960
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
    BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Laparoscopic versus open surgery for rectal cancer after neoadjuvant chemoradiation: Long-term outcomes of a propensity score matched study.
    Seshadri RA; Swaminathan R; Srinivasan A
    J Surg Oncol; 2018 Mar; 117(3):506-513. PubMed ID: 29044538
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neoadjuvant chemoradiation for rectal cancer is not associated with higher rates of thromboembolism.
    Smart PJ; Stocchi LL; Remzi FH
    Colorectal Dis; 2015 Nov; 17(11):984-9. PubMed ID: 25988216
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
    São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO
    Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
    Karagkounis G; Thai L; Mace AG; Wiland H; Pai RK; Steele SR; Church JM; Kalady MF
    Ann Surg; 2019 Jun; 269(6):1117-1123. PubMed ID: 31082910
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Minimally invasive versus open intersphincteric resection of low rectal cancer regardless of neoadjuvant chemoradiotherapy: long-term oncologic outcomes.
    Shin JK; Kim HC; Lee WY; Yun SH; Cho YB; Huh JW; Park YA
    Sci Rep; 2021 May; 11(1):11001. PubMed ID: 34040037
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
    Xu H; You G; Zhang M; Song T; Zhang H; Yang J; Jia Y; Tang J; Liang X
    World J Surg Oncol; 2019 Nov; 17(1):199. PubMed ID: 31785609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.